Sunitinib in pancreatic neuroendocrine tumors. Clinical case

by A. A. Markovich, A. A. Kuznetsova, E. L. Dronova, G. S. Emel’yanova
Published 2019-12-01

Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors

by A A Markovich, A E Kuzminov, N F Orel, A S Odintsova, G S Emelyanova, V A Gorbunova
Published 2015-09-01

Potential for use sunitinib in pancreatic neuroendocrine tumors

by A. A. Markovich, A. A. Kuznetsova, V. A. Gorbunova, N. F. Orel, A. S. Odintsova, G. S. Emelyanova, A. E. Kuzminov
Published 2019-06-01

Lanreotide for the treatment of patients with disseminated high-grade neuroendocrine tumors: the experience of application in case of unsatisfactory tolerability of octreotide

by G S Emelyanova, A E Kuzminov, N F Orel, A S Odintsova, A A Markovich, A A Kuznetsova, V A Gorbunova
Published 2016-03-01

THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT

by V. A. Gorbunova, E. A. Pigarova, L. Ya. Rozhinskaya, I. A. Voronkova, Yu. A. Krupinova, G. S. Emel’yanova, L. S. Kruglova, S. V. Shiryaev, M. B. Dolgushin, M. E. Bilik, E. A. Kobyakova, D. V. Komov
Published 2017-04-01